Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Armada Berjaya Trans Tbk (JAYA) vs Organon Pharma Indonesia Tbk. (SCPI)

Armada Berjaya Trans TbkTrading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Armada Berjaya Trans Tbk dan Organon Pharma Indonesia Tbk.: Armada Berjaya Trans Tbk diperdagangkan di Rp156 (kapitalisasi pasar 132,55 M, volume 24 jam 5,84 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Armada Berjaya Trans Tbk lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

JAYASCPI
Kapitalisasi Pasar
132,55 M104,4 M
Volume
5,84 jt
Lot
58,43 rb
Perputaran
920,63 jt
Harga Rata-rata
157,56
Nilai Transaksi
920,63 jt
Harga Ekuilibrium Indikatif
156
Volume Ekuilibrium Indikatif
2,02 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

JAYA
Lihat detail
SCPI
Lihat detail

Tentang Armada Berjaya Trans Tbk

PT Armada Berjaya Trans (“the Entity”) was established based on the Notarial Deed No. 41 dated May 30, 2012 of Myra Yuwono, S.H. The Articles of Assocation has been amended several times, and the latest changes are stated in the Notarial Deed of Christina Dwi Utami, S.H. No. 39 dated August 21, 2018, concerning in the change in the Entity’s name from PT Armada Beton to PT Armada Berjaya Trans. PT Armada Beton specialising in Cement Mixer transporter. Since 2015 the company shifted its focus into general land transport business.

Selengkapnya di halaman JAYA

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI